These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Multiple roles for neutrophils in atherosclerosis. Soehnlein O Circ Res; 2012 Mar; 110(6):875-88. PubMed ID: 22427325 [TBL] [Abstract][Full Text] [Related]
4. Role of neutrophils in atherogenesis: an update. Pende A; Artom N; Bertolotto M; Montecucco F; Dallegri F Eur J Clin Invest; 2016 Mar; 46(3):252-63. PubMed ID: 26573245 [TBL] [Abstract][Full Text] [Related]
5. Neutrophilic granulocytes - promiscuous accelerators of atherosclerosis. Drechsler M; Döring Y; Megens RT; Soehnlein O Thromb Haemost; 2011 Nov; 106(5):839-48. PubMed ID: 22012406 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil's weapons in atherosclerosis. Chistiakov DA; Bobryshev YV; Orekhov AN Exp Mol Pathol; 2015 Dec; 99(3):663-71. PubMed ID: 26551083 [TBL] [Abstract][Full Text] [Related]
7. Neutrophils in atherosclerosis: from mice to man. Döring Y; Drechsler M; Soehnlein O; Weber C Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):288-95. PubMed ID: 25147339 [TBL] [Abstract][Full Text] [Related]
8. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. de Jager SC; Bot I; Kraaijeveld AO; Korporaal SJ; Bot M; van Santbrink PJ; van Berkel TJ; Kuiper J; Biessen EA Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):e75-83. PubMed ID: 23288165 [TBL] [Abstract][Full Text] [Related]
9. Update on the role of neutrophils in atherosclerotic plaque vulnerability. Carbone F; Mach F; Montecucco F Curr Drug Targets; 2015; 16(4):321-33. PubMed ID: 25382205 [TBL] [Abstract][Full Text] [Related]
10. Neutrophils in atherosclerosis. A brief overview. Hartwig H; Silvestre Roig C; Daemen M; Lutgens E; Soehnlein O Hamostaseologie; 2015; 35(2):121-7. PubMed ID: 25385255 [TBL] [Abstract][Full Text] [Related]
12. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Baetta R; Corsini A Atherosclerosis; 2010 May; 210(1):1-13. PubMed ID: 19931081 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. Goldfine AB; Shoelson SE J Clin Invest; 2017 Jan; 127(1):83-93. PubMed ID: 28045401 [TBL] [Abstract][Full Text] [Related]
14. Targeting chemokine receptors in chronic inflammatory diseases: an extensive review. Koelink PJ; Overbeek SA; Braber S; de Kruijf P; Folkerts G; Smit MJ; Kraneveld AD Pharmacol Ther; 2012 Jan; 133(1):1-18. PubMed ID: 21839114 [TBL] [Abstract][Full Text] [Related]
16. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Little PJ; Chait A; Bobik A Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiological role of neutrophils in acute myocardial infarction. Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F Thromb Haemost; 2013 Sep; 110(3):501-14. PubMed ID: 23740239 [TBL] [Abstract][Full Text] [Related]
18. Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases. Boppana NB; Devarajan A; Gopal K; Barathan M; Bakar SA; Shankar EM; Ebrahim AS; Farooq SM Exp Biol Med (Maywood); 2014 May; 239(5):509-18. PubMed ID: 24625439 [TBL] [Abstract][Full Text] [Related]
19. Chemokines in atherosclerosis: an update. Zernecke A; Shagdarsuren E; Weber C Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299 [TBL] [Abstract][Full Text] [Related]